8-KMaterial AgreementsShareholder MattersCorporate Changes+2

DARDEN RESTAURANTS INC 8-K Report, Material Agreement (Nov 13, 2014)

Filed November 13, 2014For Securities:DRI

Summary

Darden Restaurants, Inc. (DRI) filed an 8-K on November 13, 2014, detailing significant corporate governance reforms approved by its Board of Directors. These changes are designed to enhance responsiveness to shareholders and improve governance practices. Key actions include the immediate termination of the company's "poison pill" shareholder rights plan and amendments to its bylaws to implement a majority voting standard for director elections in uncontested situations. Furthermore, Darden has agreed to settle outstanding derivative litigation, which involves repealing certain advance notice bylaw amendments adopted earlier in 2014. The company also announced its commitment to seeking shareholder approval for several additional governance initiatives at its 2015 annual meeting. These proposed changes aim to further empower shareholders, including lowering the threshold for shareholders to call a special meeting, eliminating supermajority voting requirements for certain charter amendments and director removals, and simplifying provisions related to business combinations with interested shareholders. These moves signal a strategic shift towards greater shareholder alignment and a more streamlined governance structure.

Key Highlights

  • 1Termination of the "poison pill" shareholder rights plan, with rights set to expire on November 28, 2014.
  • 2Implementation of a majority voting standard for director elections in uncontested annual meetings.
  • 3Settlement of derivative litigation, leading to the repeal of certain advance notice bylaw amendments.
  • 4Adoption of an anti-hedging and anti-pledging policy for executive officers, directors, and employees.
  • 5Enhancements to political contributions and lobbying disclosure policies.
  • 6Commitment to seeking shareholder approval in 2015 to allow shareholders holding 10% of voting stock to call a special meeting.
  • 7Commitment to seeking shareholder approval in 2015 to eliminate supermajority voting standards for certain charter amendments and director removals.

Frequently Asked Questions

Terminating the 'poison pill' (Rights Agreement) removes a significant anti-takeover measure. This means that a hostile takeover attempt would be more feasible if a party were to acquire a substantial amount of Darden's stock. For investors, it can indicate a willingness by the company to be more responsive to shareholder interests, potentially making the stock more attractive to activist investors or potential acquirers.

Under the new majority voting standard, directors in uncontested elections must receive more 'for' votes than 'against' votes. Previously, a plurality standard meant a director could be elected with less than a majority if there were multiple candidates. This change gives shareholders more direct power in electing directors and holding them accountable for performance.

Shareholders will be asked to approve several key changes, including lowering the threshold for shareholders to call a special meeting to 10% of voting stock (from 50%), eliminating supermajority voting requirements for certain charter amendments and for removing directors for cause, and simplifying rules around business combinations with interested shareholders. These proposals aim to give shareholders more influence and reduce potential governance roadblocks.

The settlement of derivative litigation requires Darden to repeal certain advance notice bylaw amendments that were adopted earlier in 2014. These repealed amendments had imposed stricter requirements on shareholders wishing to nominate directors or propose business at meetings. Their removal reverts to a less restrictive process for shareholder engagement.